208 related articles for article (PubMed ID: 2321175)
1. Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia.
Peat JK; Woolcock AJ; Cullen K
Thorax; 1990 Jan; 45(1):32-7. PubMed ID: 2321175
[TBL] [Abstract][Full Text] [Related]
2. Rate of decline of lung function in subjects with asthma.
Peat JK; Woolcock AJ; Cullen K
Eur J Respir Dis; 1987 Mar; 70(3):171-9. PubMed ID: 3569449
[TBL] [Abstract][Full Text] [Related]
3. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Islam SS; Schottenfeld D
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal decline in lung function: a community-based cohort study in Korea.
Leem AY; Park B; Kim YS; Chang J; Won S; Jung JY
Sci Rep; 2019 Sep; 9(1):13614. PubMed ID: 31541126
[TBL] [Abstract][Full Text] [Related]
5. Chronic respiratory symptoms, von Willebrand factor and longitudinal decline in FEV1.
Chambers DC; Boldy DA; Ayres JG
Respir Med; 1999 Oct; 93(10):726-33. PubMed ID: 10581662
[TBL] [Abstract][Full Text] [Related]
6. Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.
Guerra S; Halonen M; Vasquez MM; Spangenberg A; Stern DA; Morgan WJ; Wright AL; Lavi I; Tarès L; Carsin AE; Dobaño C; Barreiro E; Zock JP; Martínez-Moratalla J; Urrutia I; Sunyer J; Keidel D; Imboden M; Probst-Hensch N; Hallberg J; Melén E; Wickman M; Bousquet J; Belgrave DC; Simpson A; Custovic A; Antó JM; Martinez FD
Lancet Respir Med; 2015 Aug; 3(8):613-20. PubMed ID: 26159408
[TBL] [Abstract][Full Text] [Related]
7. Predictors of accelerated FEV
Baarnes CB; Thuesen BH; Linneberg A; Ustrup AS; Pedersen SK; Ulrik CS
Chron Respir Dis; 2019; 16():1479973119838278. PubMed ID: 31159575
[TBL] [Abstract][Full Text] [Related]
8. Decline of the lung function related to the type of tobacco smoked and inhalation.
Lange P; Groth S; Nyboe J; Mortensen J; Appleyard M; Jensen G; Schnohr P
Thorax; 1990 Jan; 45(1):22-6. PubMed ID: 2321172
[TBL] [Abstract][Full Text] [Related]
9. Analysis of FEV1 decline in relatively healthy heavy smokers: implications of expressing changes in FEV1 in relative terms.
Thomsen LH; Dirksen A; Shaker SB; Skovgaard LT; Dahlbäck M; Pedersen JH
COPD; 2014 Feb; 11(1):96-104. PubMed ID: 24111638
[TBL] [Abstract][Full Text] [Related]
10. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.
Tashkin DP; Altose MD; Connett JE; Kanner RE; Lee WW; Wise RA
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1802-11. PubMed ID: 8665038
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of PM10 pollution on pulmonary function of smokers with mild to moderate chronic obstructive pulmonary disease.
Pope CA; Kanner RE
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1336-40. PubMed ID: 8503541
[TBL] [Abstract][Full Text] [Related]
12. Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study.
Caramori G; Fabbri M; Paioli D; Falcone F; Severino C; Felisatti G; Arar O; Adcock IM; Fan Chung K; Barnes PJ; Ciaccia A; Papi A
Monaldi Arch Chest Dis; 2005 Jun; 63(2):84-7. PubMed ID: 16128222
[TBL] [Abstract][Full Text] [Related]
13. [Effect of smoking on the decline in forced expiratory volume in one second].
Sato K; Kioi S; Arakawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):288-93. PubMed ID: 9168644
[TBL] [Abstract][Full Text] [Related]
14. Rates of decline in lung function among subjects who restart cigarette smoking.
Sherrill DL; Enright P; Cline M; Burrows B; Lebowitz MD
Chest; 1996 Apr; 109(4):1001-5. PubMed ID: 8635322
[TBL] [Abstract][Full Text] [Related]
15. Severity of airflow limitation is associated with severity of airway inflammation in smokers.
Di Stefano A; Capelli A; Lusuardi M; Balbo P; Vecchio C; Maestrelli P; Mapp CE; Fabbri LM; Donner CF; Saetta M
Am J Respir Crit Care Med; 1998 Oct; 158(4):1277-85. PubMed ID: 9769292
[TBL] [Abstract][Full Text] [Related]
16. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
17. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
18. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking.
James AL; Palmer LJ; Kicic E; Maxwell PS; Lagan SE; Ryan GF; Musk AW
Am J Respir Crit Care Med; 2005 Jan; 171(2):109-14. PubMed ID: 15486340
[TBL] [Abstract][Full Text] [Related]
19. Lung function decline in male heavy smokers relates to baseline airflow obstruction severity.
Mohamed Hoesein FAA; Zanen P; Boezen HM; Groen HJM; van Ginneken B; de Jong PA; Postma DS; Lammers JJ
Chest; 2012 Dec; 142(6):1530-1538. PubMed ID: 22722231
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.
Saetta M; Di Stefano A; Turato G; Facchini FM; Corbino L; Mapp CE; Maestrelli P; Ciaccia A; Fabbri LM
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):822-6. PubMed ID: 9517597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
